Your session is about to expire
← Back to Search
Behavioral Intervention
HEART Camp Connect for Heart Failure
N/A
Waitlist Available
Led By Windy W Alonso, PhD, RN
Research Sponsored by University of Nebraska
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3 months to 6 months
Awards & highlights
Study Summary
This trial tests a new intervention for heart failure patients to increase long-term exercise adherence. It combines videoconference coaching, hospital-based exercise facilities and online exercise programs.
Eligible Conditions
- Heart Failure
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 3 months to 6 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3 months to 6 months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Secondary outcome measures
The number of potential participants without smart devices
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: HEART Camp ConnectExperimental Treatment1 Intervention
Participants will have access to a virtual exercise platform or membership to a medical exercise facility. Participants will meet with a virtual exercise coach via Zoom on a weekly basis.
Group II: Usual CareActive Control1 Intervention
Participants will have access to a virtual exercise platform or membership to a medical exercise facility.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
HEART Camp Connect
2022
N/A
~20
Find a Location
Who is running the clinical trial?
University of NebraskaLead Sponsor
539 Previous Clinical Trials
1,144,723 Total Patients Enrolled
12 Trials studying Heart Failure
1,029 Patients Enrolled for Heart Failure
Windy W Alonso, PhD, RNPrincipal InvestigatorUniversity of Nebraska
2 Previous Clinical Trials
4 Total Patients Enrolled
1 Trials studying Heart Failure
2 Patients Enrolled for Heart Failure
Windy Alonso, PhD, RNPrincipal InvestigatorUniversity of Nebraska
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You had a heart attack, heart surgery, or got a pacemaker less than 6 weeks ago.You have an implantable device that helps control your heart rhythm.You have had an ultrasound of your heart in the past year.You have bone or muscle problems that make it hard for you to do aerobic exercise.You have been diagnosed with heart failure and your heart's pumping function is above a certain level.You have a serious illness that might prevent you from finishing the study.You are not fit enough to safely do exercise.You have unstable angina or experience significant shortness of breath with light activity.Your score on a diagnostic test is less than 6.You have signs of severe heart failure.
Research Study Groups:
This trial has the following groups:- Group 1: HEART Camp Connect
- Group 2: Usual Care
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are there current openings available for participants in this trial?
"The trial is still recruiting according to clinicaltrials.gov, with its initial posting occurring on March 28th 2022 and the most recent update made on August 9th 2023."
Answered by AI
What is the aggregate amount of individuals participating in this research?
"Affirmative. On clinicaltrials.gov, it is indicated that this medical trial commenced on the 28th of March 2022 and was most recently amended on the 9th of August 2023. Presently, 50 patients must be recruited for a single site to complete this study's enrollment requirements."
Answered by AI
Recent research and studies
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger